Impact of neoadjuvant treatment on the feasibility of breast conserving surgery for Chinese women by Kwong, A & Chow, LCY
Title Impact of neoadjuvant treatment on the feasibility of breastconserving surgery for Chinese women
Author(s) Chow, LCY; Kwong, A
Citation
The 2015 Global Breast Cancer Conference (GBCC 2015) and 4th
International Breast Cancer Symposium (IBCS), Jeju Island,
South Korea, 23-25 April 2015. In Abstracts Book, 2015, p. 375
Issued Date 2015
URL http://hdl.handle.net/10722/215353
Rights Creative Commons: Attribution 3.0 Hong Kong License
    375
Poster 
Exhibition
Global Breast Cancer Conference 2015 & 
4th International Breast Cancer Symposium
Treatment
PO172
Impact of Neoadjuvant Treatment on the Feasibility of 
Breast Conserving Surgery for Chinese Women 
Lorraine Chow*, Ava Kwong 
Department of Breast Surgery, University of Hong Kong, Hong Kong 
Background/Purpose: Neo-adjuvant chemotherapy could improve the rate of Breast 
Conserving Surgery (BCS) for Western women. However, there is a scarcity of data if 
this could also be applied for Chinese women. 
Methods: From January 1996 to December 2012, a total of 557 patients were treated 
for breast cancer in the Department of Surgery at Queen Mary Hospital and they 
formed the focus of this study. Their clinicopathological data and treatment outcome 
were reviewed. 
Results: 82.0% patients had invasive ductal carcinoma before operation. A total of 95 
patients had either grade I or II tumors. estrogen receptor, progesterone receptor and 
c-erb B2 positivity were detected in 28.0%, 21.3% and 35.0% of the patients. With re-
spect to the choice of treatment, 85.0% of patients were proposed for mastectomy. After 
neo-adjuvant treatment, 67.0% patients underwent mastectomy and the remaining 
23.0% patients underwent wide local excision. 8.2% patients also underwent recon-
struction after mastectomy. Sentinel lymph node biopsy was performed in 11.8% pa-
tients and axillary dissection was performed in 74.9% patients. 
Conclusion: Neo-adjuvant treatment could successfully convert around 20% breast 
cancer patients with initially proposed mastectomy to BCS in Chinese women. 
